Please assess the completion status of the following clinical trial:

Trial Title: Study Of RV-39 In Patients Who Also Have Asthma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Have asthma for at least 3 months prior to the study.~* Have been using an allowed pre-study asthma therapy for at least 3 months prior to study.~* Demonstrate airway hyperresponsiveness following inhalation of bronchoconstrictor.~* Have a positive allergic status antibody test.~Exclusion Criteria:~* Have a history of life-threatening asthma.~* Been hospitalized for asthma within the 24 months prior to the study.~* Have certain conditions that would make study participation unsafe.~* The study doctor will evaluate other inclusion and exclusion criteria.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- Arm 1 (Type: ACTIVE_COMPARATOR): None
- Arm 2 (Type: ACTIVE_COMPARATOR): None
- Arm 3 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).